Subscribe to Our Blog. Stay up to date with the latest news and insights.
An industry-wide drive to speed study start-up Life science industry reports indicate that the early stages of study start-up take twice as long today as they did five years ago. The primary reason may be that, as trials have grown in complexity, so too have data collection activities related to site identification, feasibility ranking, and…
Remarque Systems Tech Platform These days, data comes from a host of sources. It may be patient reported or captured electronically or identified by a specialty lab. It’s not limited to clinical safety and efficacy information; technology can now measure and oversee trial performance, quality, cost, and compliance. Companies are importing and integrating data, then…
Picking the right technology platform can be a game changer for the way your company analyzes data and runs clinical trials. The right data platform can not only help you mitigate risk, increase patient safety, and keep your trial on track, it can evolve with your shifting needs — and the ever-changing clinical trial landscape.…
ICH E6 (R3): The foundation for Modern Clinical Research Three decades ago, an international committee came together to create a revolutionary document designed to improve the efficiency of new drug development. Dubbed ICH E6, it has provided consistent guidance for clinical trials around the world. Today, plans are underway to update it for the second…
Delayed data delivery is a growing problem It’s 2021, and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access to data is not the norm — and that lack can create a cascading set of issues affecting every aspect of a study. With critical decisions too often being made…
Effective Trial Continuity In the Face of a Pandemic While social distancing and isolation are paramount, clinical trials must adapt to remain viable. However, many clinical trial sponsors still have questions about how to effectively gather collective insights and apply them to improve their clinical trials. The result is a call for risk-based quality management…
Get the straight story on RBM in our new white paper Over the past few years, there has been much debate regarding the definition of risk-based monitoring. To put it in context, clinical monitoring – otherwise known as “traditional” monitoring – describes the oversight and administrative efforts involved in monitoring both a participant’s health and…
RBM (Risk-Based Monitoring) has been gaining traction since 2010 and has been called “the future of clinical trials.” This infographic explores what it means to truly perform RBM and how this method can improve speed, quality, and reduce the costs of a clinical trial. Download Whitepaper